Weave Bio Therapeutics


Silk. For Hollow Organ Regeneration. Platform technology that enables hollow organ regeneration using bioresorbable, non-immunogenic silk scaffolds. Preclinical validation in urethral strictures, hypospadius, bladder augmentation, ureteral strictures and ileal conduits.

Weave Bio Therapeutics

Weave Bio Therapeutics

Weave Bio Therapeutics is currently seeking investment

Weave Bio Therapeutics is seeking a series-a investment in the range of 5m-20m

All Investment-seeking Members


Key People

Vikas Agarwal

CEO

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.